Nirmatrelvir/Ritonavir [Paxlovid]

Abbreviation
NA
Disease(s)
Covid 19
Background
.pdf
Patent oppositions filed in
Honduras

An oral antiviral medication used to treat mild to moderate Covid 19 infection.

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Honduras17-02-2025ITPC LATCAPre-GrantUnder ExaminationMoleculesHN/P/2021/002695 WO2021250648View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top